U.S. RESEARCH ROUNDUP-Highpeak Energy, Nordstrom, Victoria'S Secret & Co

Reuters03-07

March 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Highpeak Energy, Nordstrom and Victoria'S Secret & Co, on Thursday.

HIGHLIGHTS

* Highpeak Energy Inc : Gerdes Energy Research cuts to sell from buy

* Nordstrom Inc : Jefferies cuts to hold from buy

* Victoria'S Secret & Co : JP Morgan cuts to underweight from neutral

Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.

* Abercrombie & Fitch Co : Jefferies raises target price to $155 from $149

* Abercrombie & Fitch Co : JP Morgan raises target price to $125 from $109

* Aquestive Therapeutics Inc : Wedbush raises target price to $9 from $4

* Astrana Health Inc : Jefferies raises target price to $51 from $50

* Biohaven Ltd : JP Morgan raises target price to $57 from $56

* Bridgebio pharma Inc : Leerink Partners cuts target price to $57 from $59

* Brown-Forman Corp : RBC cuts target price to $56 from $60

* Campbell Soup Co : JP Morgan cuts target price to $45 from $48

* Cytokinetics Inc : JP Morgan cuts target price to $77 from $78

* Dermtech Inc : BTIG cuts target price to $2 from $4

* Elevation Oncology Inc : Leerink Partners raises target price to $10 from $8

* European Wax Center Inc : Piper Sandler cuts target price to $18 from $20

* Foot Locker Inc : Barclays cuts target price to $22 from $26

* Foot Locker Inc : Jefferies cuts target price to $24 from $25

* Foot Locker Inc : JP Morgan cuts target price to $23 from $26

* Foot Locker Inc : Piper Sandler cuts target price to $31 from $37

* Highpeak Energy Inc : Gerdes Energy Research cuts target price by $8 to $12

* Highpeak Energy Inc : Gerdes Energy Research cuts to sell from buy

* Newtekone Inc : Piper Sandler cuts target price to $13 from $14

* Nordstrom Inc : Jefferies cuts to hold from buy

* Nordstrom Inc : Jefferies cuts target price to $17 from $18

* Onespan Inc : D.A. Davidson raises target price to $12 from $9.5

* Pacira Biosciences Inc : JP Morgan assumes with overweight rating

* Pacira Biosciences Inc : JP Morgan assumes with price target $45

* Tarsus Pharmaceuticals Inc : Jefferies raises target price to $44 from $30

* Triplepoint Venture Growth BDC Corp : Piper Sandler cuts PT to $10 from $11

* United Natural Foods Inc : Jefferies cuts target price to $13.5 from $15

* Viavi Solutions Inc : Susquehanna raises target price to $14 from $12

* Victoria'S Secret & Co : JP Morgan cuts target price to $15 from $22

* Victoria'S Secret & Co : JP Morgan cuts to underweight from neutral

* Wesco International Inc : Oppenheimer raises target price to $190 from $175

* Zymeworks Inc : Jefferies raises target price to $14 from $13

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment